alexa Toxicology: The Basis for Development of Antidotes | OMICS International
ISSN: 2476-2067
Toxicology: Open Access

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Toxicology: The Basis for Development of Antidotes

Saganuwan AS*

Department Of Veterinary Physiology, Pharmacology and Biochemistry, University Of Agriculture, P. M. B. 2373, Makurdi, Benue State, Nigeria

*Corresponding Author:
Saganuwan A
Department Of Veterinary Physiology
Pharmacology and Biochemistry, College Of Veterinary Medicine
University Of Agriculture, Benue State, Nigeria
Tel: +2347039309400
E-mail: [email protected]

Received date: October 6, 2015 Accepted date: October 10, 2015 Published date: October 13, 2015

Citation: Saganuwan AS (2015) Toxicology: The Basis for Development of Antidotes. Toxicol open access 1:e101. doi:10.4172/2476-2067.1000e101

Copyright: © 2015 Saganuwan A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Toxicology: Open Access

Editorial

Toxicology is the study of poison. Sources of poisons include animals, microorganisms, plants and chemicals. Although, Paracelsus who was a lecturer at the University of Basel, Switzerland in 1520s had hypothesized that the ability of an agent to cause poisoning is dependent on the dose of that agent. It was on this basis the median lethal dose (LD50) was introduced in 1920. LD50 is the dose which has proven to cause death to 50% of the test group of animals [1]. It is an initial assessment of toxic manifestations and is one of the initial screening experiments usually performed with carcinogenic, anticarcinogenic, venomous, anti-venomous, toxicogenic, anti-toxicogenic, immunogenic and anti-immunogenic compounds. An antidote is any is any substance that counteracts a poison by, (a) chemically destroying the poison, (b) mechanically preventing absorption, or (c) physiologically opposing the effects of the poison in the body after absorption [2]. The data from median lethal estimation serve as the basis for classification and labelling; provide initial information on the mode of toxic substance; help arrive at a dose of a new compound and help determine LD50 values that may indicate potential types of drug activity [3]. The different methods used in determination of LD50 include Arithmetical method of Karber [4], Lorke method [5], arithmetical method of Reed and Muench [6], graphical method of Miller and Tainter [7], graphical method of Litchfield and Wilcoxon [8], revised up-and-down procedure [9], a modified arithmetical method of Reed and Muench [6] and arithmetic-geometric-harmonic method. All the methods employ summation of the doses of toxicant that caused death in the test group of animals.

However, for Reed and Muench method, the sum of cumulative dead and cumulative survived of each dose is taken. The percent survival to two doses adjacent to LD50 is calculated and the LD50 determined [10]. In another report, LD50 is calculated using the data on percent mortality instead of percent survival [11]. Having noted the marked difference between the estimated LD50 from percent survival and percent mortality using Reed and Muench method, Saganuwan [1] modified and validated the method using the average of median lethal dose (LD50) and median survival dose (MSD50) which gave a relatively ideal LD50. The method was also validated by other authors with precision and accuracy. Kue et al. [12] used quick chick embryo chorioallantoic membrane (CAM) as an alternative predictive model in acute toxicological studies for cyclophosphamide, cisplatin, vincristine, carmustin, campothecin, aloin, mitomycin-C, actinomycin–D, melphalan and paclitaxel. The authors used the method of Reed and Muench modified by Saganuwan [1], and determined LD50 of all the anticancer agents and there was significant correlation between the ideal LD50 for the CAM and LD50 for mice. Signifying the versatility of the revised Reed and Muench method using CAM model as a replacement for toxicological studies in rodents.

World Health Organization (WHO) [13] has patented sodium silicate complex (SSC) which comprises trimeric sodium silicate (Na2SiO3)3 and sodium silicate pentahydrate (Na2SiO3)5H2O. SSC has antivenomous activity against Crotalus atrox , Agkistrodon contortrix contortrix and Agkistrodon piscivorus leucostoma venoms using two enzymatic assays, gelatinase and hide powder azure assays at pH of 14. The LD50 of SSC was determined in mice after 48 hrs. The calculations for the LD50 were generated by a program on the NNTRC hompage (ntrc.tamuk.edu/LD50calculator.xls), which was based on the method developed by Saganuwan [1]. The anti-lethal dose assay was performed to determine the effective dose of LIPH that neutralized LD50s of the snake venoms using the method of Sanchez et al. [14]. But Cao et al. [15], identified a Bacteriovorax sp. isolate as a potential bacterium against snake head fish-pathogenic Aeromonas veronii using the modified method of Reed and Muench [1]. Aeromonasis is a serious problem in world aquaculture caused by Aeromonas veronii which affects quality of fish such as Ictadarus punctatus , Colisa lalia , Misgrunus anquithcaudatus , Acipenser baelii , Astronotus ocellatus and Lewcassi longinostris leading to severe losses and marketing [15]. Kothari et al. [16] reported that a bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumonia strains and Salmonella typhimunum using method developed by Saganuwan.

Since LD50 was used to determine toxicity level of snake venom and anti-venom, anticancer drugs, Aero monas veronii pathogen and bivalent conjugate vaccine against Streptococcus pneumonia strains and Salmonella typhimunum using the method of Reed and Muench as modified by Saganuwan, there is every reason to believe that toxicology could be the basis for development of antidotes against cancers, snakes venoms, microbial pathogen and systemic immunogens [16].

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 9659
  • [From(publication date):
    December-2015 - Aug 11, 2020]
  • Breakdown by view type
  • HTML page views : 9449
  • PDF downloads : 210
Top